Identification of growth hormone receptor as a relevant target for precision medicine in low‐EGFR expressing glioblastoma

OBJECTIVE: New therapeutic approaches are needed to improve the prognosis of glioblastoma (GBM) patients. METHODS: With the objective of identifying alternative oncogenic mechanisms to abnormally activated epidermal growth factor receptor (EGFR) signalling, one of the most common oncogenic mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Verreault, Maïté, Segoviano Vilchis, Irma, Rosenberg, Shai, Lemaire, Nolwenn, Schmitt, Charlotte, Guehennec, Jérémy, Royer‐Perron, Louis, Thomas, Jean‐Léon, Lam, TuKiet T., Dingli, Florent, Loew, Damarys, Ducray, François, Paris, Sophie, Carpentier, Catherine, Marie, Yannick, Laigle‐Donadey, Florence, Rousseau, Audrey, Pigat, Natascha, Boutillon, Florence, Bielle, Franck, Mokhtari, Karima, Frank, Stuart J., de Reyniès, Aurélien, Hoang‐Xuan, Khê, Sanson, Marc, Goffin, Vincent, Idbaih, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270581/
https://www.ncbi.nlm.nih.gov/pubmed/35808822
http://dx.doi.org/10.1002/ctm2.939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270581/
https://www.ncbi.nlm.nih.gov/pubmed/35808822
http://dx.doi.org/10.1002/ctm2.939

Ejemplares similares